Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.

Registrieren

STRO Sutro Biopharma Inc

3,815

-0,085 (-2,18%)

Zuletzt aktualisiert: 17:15:22

Verzögert um 15 Minuten

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Article too big to display. Click here to view on the SEC website

Sutro Biopharma (NASDAQ:STRO)
Historical Stock Chart
Von Mai 2024 bis Jun 2024

Click Here for more Sutro Biopharma Charts.

Sutro Biopharma (NASDAQ:STRO)
Historical Stock Chart
Von Jun 2023 bis Jun 2024

Click Here for more Sutro Biopharma Charts.

News Sutro Biopharma Inc

Form 4 - Statement of changes in beneficial ownership of securities
Montag 10 Juni 2024 (3 Tage vor) • Edgar (US Regulatory)

Form 8-K - Current report
Montag 10 Juni 2024 (3 Tage vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Montag 10 Juni 2024 (3 Tage vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Montag 10 Juni 2024 (3 Tage vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Montag 10 Juni 2024 (3 Tage vor) • Edgar (US Regulatory)

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Freitag 17 Mai 2024 (4 Wochen vor) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Montag 13 Mai 2024 (1 Monat vor) • Edgar (US Regulatory)

Form 8-K - Current report
Montag 13 Mai 2024 (1 Monat vor) • Edgar (US Regulatory)

Sutro Biopharma Reports First Quarter 2024 Financial Results, Business Highlights and Select Anticipated Milestones
Montag 13 Mai 2024 (1 Monat vor) • GlobeNewswire Inc.

Sutro Biopharma Announces Initiation of Randomized Portion (Part 2) of REFRαME-O1 Trial
Dienstag 30 April 2024 (1 Monat vor) • GlobeNewswire Inc.

Sutro Biopharma Announces Pricing of $75 Million Underwritten Offering
Dienstag 2 April 2024 (2 Monate vor) • GlobeNewswire Inc.

Sutro Biopharma Reports Full Year 2023 Financial Results, Business Highlights and Select Anticipated Milestones
Montag 25 März 2024 (3 Monate vor) • GlobeNewswire Inc.

Weitere Sutro Biopharma Inc News-Artikel

Marsh E McLennan Cos

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen